在药物诱导的急性间歇性炎后,功能恢复的预测工具
Fernando Caravaca-Fontán1, Marina Alonso-Riaño2, Amir Shabaka3
1Department of Nephrology, Instituto de Investigación Hospital "12 de Octubre" (imas12), Madrid, Spain.
概括
一个新的诺米图预测药物诱导的急性间歇性炎 (DI-AIN) 患者的功能恢复,这些患者接受皮质类固醇治疗. 这种工具有助于临床医生估计预后并优化治疗以获得更好的结果.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
- 医学诊断 医学诊断 医学诊断
背景情况:
- 药物诱导的急性间歇性炎 (DI-AIN) 是急性损伤的常见原因.
- 目前的治疗包括药物戒断和皮质类固醇.
- 预测康复对于患者管理至关重要.
研究的目的:
- 开发和验证DI-AIN患者在6个月后恢复功能的预测性诺米克图.
- 确定功能完全或完全没有恢复的关键预测因素.
主要方法:
- 一项多中心的回顾性观察性研究包括224名活检证明的DI-AIN患者,这些患者接受了皮质类固醇治疗.
- 数据被分为培训 (n=164) 和验证 (n=60) 集.
- 对于一个多变量逻辑回归模型,最小绝对收缩和选择操作员回归确定了预测因素.
主要成果:
- 诺米图表显示出良好的区分能力,AUC为0.79 (95% CI:0.71-0.88).
- 关键预测因素包括年龄,性别,间歇性纤维化和开始使用皮质类固醇的时间.
- 模型校准和临床实用性通过引导验证和决策曲线分析得到证实.
结论:
- 经过验证的诺米克图可以预测DI-AIN患者接受皮质类固醇治疗的6个月脏恢复.
- 该工具帮助临床医生量身定制皮质类固醇治疗强度和持续时间.
- 诺米图支持改进的治疗策略和患者预后.
相关概念视频
01:17Factors Affecting Renal Clearance: Renal Impairment
48
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
48
01:11Renal Failure: Dose Adjustments
56
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
56
01:25Renal Drug Excretion: Tubular Reabsorption
85
Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
85
01:08Renal Drug Clearance: Comparison Between Renal Excretion Methods
59
Renal clearance is a critical parameter encompassing kidney filtration, secretion, and reabsorption processes. It is calculated using a specific equation to determine the rate at which the kidneys clear a drug.
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
59
01:28Renal Drug Excretion: Tubular Secretion
104
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
104
01:06Renal Drug Clearance: Overview
104
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
104